Skip to content

Codman Skull Pins (Adult & Child), Reusable

by Codman & Shurtleff, Inc.

510(k) K912005

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK912005 Date19 Sep 1991ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
HBL
Device Class
Class II
Regulation
21 CFR Part 882.4460
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Codman Skull Pins (Adult & Child), Reusable are classified as Holder, Head, Neurosurgical (Skull Clamp) under product code HBL. These devices are designed to secure and stabilize the skull during neurosurgical procedures, providing a stable fixation point for cranial operations in both adult and pediatric patients.

Intended for reusable use, these skull pins are regulated under FDA 510(k) clearance K912005, classified as Class II with Special Controls. They are supplied sterile and intended for use in operating room settings, adhering to regulatory standards outlined in 21 CFR 882.4460. The device was reviewed by the Neurology (NE) Advisory Committee and cleared as substantially equivalent in 1991.

Other devices from Codman & Shurtleff, Inc.

See all devices from Codman & Shurtleff, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these Codman Skull Pins meant for single-use or can they be reused in multiple procedures?

    These Codman Skull Pins are explicitly designed for reusable use, as stated in the device description. They are intended to be sterilized and used repeatedly in operating room settings, adhering to regulatory standards for reusable medical devices.

  • How are these skull pins supplied, and are they sterile upon receipt?

    The Codman Skull Pins (Adult & Child) are supplied sterile, as noted in the device description. This ensures they meet operating room requirements without additional sterilization before first use, though they are intended for reuse after proper cleaning and reprocessing.

  • What regulatory pathway was followed for FDA clearance of these skull pins, and what does that mean for their use?

    These pins were cleared via the FDA 510(k) process (K912005), classified as Class II with Special Controls, and reviewed by the Neurology (NE) Advisory Committee in 1991. The clearance determined they are substantially equivalent to a predicate device, meaning their safety and performance meet established regulatory standards for neurosurgical skull clamps.

  • What sizes or models of Codman Skull Pins are available, and are they designed for both adult and pediatric patients?

    While the exact sizes or model variations aren’t detailed in the provided data, the device is explicitly labeled as Codman Skull Pins (Adult & Child), indicating it includes designs suitable for both adult and pediatric neurosurgical procedures. The OpenFDA registration numbers suggest multiple variants exist, but specifics would require manufacturer documentation.

  • Where were these skull pins originally submitted to the FDA, and what was the decision date for clearance?

    The initial submission was filed at 41 Pacella Park Dr., Randolph, MA 02368, and the FDA clearance decision was made on September 19, 1991, following a review by the Neurology Advisory Committee. The clearance was granted under the Traditional 510(k) pathway with a decision code of SESE (Substantially Equivalent).